Spravato comes as a solution in a nasal spray bottle that you’ll inhale. Each nasal spray bottle releases two sprays for a total of 28 milligrams (mg) of esketamine. For treatment-resistant ...

The FDA approved esketamine (Spravato) nasal spray as monotherapy ... with least-square mean differences of -5.1 with the ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment ... March – has a wholesale acquisition cost of $295 per 28 mg device and costs around $32,400 for a year’s treatment ...

The accelerating sales growth of Johnson & Johnson's Spravato could go up yet another gear after the FDA approved a third indication for the novel antidepressant. Spravato (esketamine) has become ...